Hamps Bio Limited IPO

Apply 0
Avoid 0

The company is specialize in the ethical marketing and distribution of pharmaceutical formulation products (Pharma) and the manufacturing of freeze-dried and frozen products (FDFP). Their diverse product portfolio and strategic market presence cater to both the healthcare and FMCG sectors, establishing a strong foothold in the industry.

Product Segments

i. Pharmaceutical Products                 ii. Freeze-Dried and Frozen Products (FDFP)

Market Presence

i. Distribution Network:
a. Over 50 distributors as of October 31, 2024.
b. Strong presence across 8 Indian states and union territories for Pharma products.
c. FDFP products are sold in 6 countries and 22 Indian states and union territories.

ii. E-commerce Channels: Active presence on leading platforms such as Amazon (global marketplaces: .com, .ca, .eu), Flipkart, and JioMart, ensuring accessibility to a wide customer base.

Product Portfolio

i. A comprehensive portfolio of 180+ products across both the Pharma and FDFP segments.
ii. The products address the demands of healthcare, nutrition, and FMCG markets, offering innovative and quality-driven solutions.

Brand Recognition

i. Hamps: A trusted brand in the pharmaceutical sector, known for ethical marketing and high-quality medicinal and nutritional products.
ii. FzyEzy: An emerging brand in the freeze-dried and frozen food segment, recognized for its premium quality and innovative offerings.

Their diversified operations, spanning multiple sectors and geographies, position them as a versatile player in both the pharmaceutical and FMCG industries. By leveraging their robust distribution network and e-commerce capabilities, they continue to grow their market presence and deliver quality products to a global audience.

Objects of the Hamps Bio Limited IPO:

The Company intends to use its proceeds as follows: i. Purchase of plant & machinery for FMCG division ii. Enhancing the visibility and awareness of the brand iii. General corporate purposes.
DRHP of Hamps Bio Limited IPO
RHP of Hamps Bio Limited IPO

Hamps Bio Limited IPO Details:

Open Date: Dec 13 2024
Close Date: Dec 17 2024
Total Shares: 1,220,000
Face Value: ₹ 10 Per Equity Share
Issue Size: 6.22 Cr.
Lot Size: 2000 Shares
Issue Price: ₹ 51 Per Equity Share
Listing At: BSE SME
Listing Date: Dec 20 2024

Promoters And Management:

Herrik Shah, 42, is the Promoter, Chairman, and Managing Director of the Company. He holds a Bachelor's in Pharmacy and a Diploma in Export and Import. With over 20 years of experience in pharmaceutical formulations, Herrik has been with the Company since its inception and was appointed Chairman and Managing Director in November 2023 for a five-year term. He oversees strategy, performance, risk management, innovation, and market expansion. Shrenik Shah, 39, is a Promoter and Whole-Time Director of the Company. He holds an M.S. in Orthopedics from Sardar Patel University and an MBBS from South Gujarat University. With nearly 16 years of experience in pharmaceuticals and product development, Shrenik has been with the Company since its inception. He was appointed Chairman and Managing Director on December 8, 2023, for a five-year term, and currently oversees product development and system management. Pallavi Shah, 45, is a Promoter and Non-Executive Director of the Company, appointed on June 15, 2024. She holds a Bachelor of Pharmacy from the University of Pune and has over 20 years of experience in the pharmaceutical industry. Pallavi specializes in team management and product development.

Financials of Hamps Bio Limited IPO:

In Cr.
Particulars Oct 31st, 2024 FY 24 FY 23 FY 22
Revenue from operations 4.26 6.47 5.57 5.34
Growth in Revenue 16.16% 4.31%
EBITDA 0.65 (15.32%) 1.17 (18.18%) 0.86 (15.53%) 0.61 (11.52%)
PAT 0.34 (7.99%) 0.50 (7.73%) 0.35 (6.44%) 0.12 (2.28%)
D/E Ratio 0.37 0.31 1.27 2.03
RONW 9.19% 14.84% 26.34% 12.08%
CFOA 0.74 (0.29) 1.22 0.33

Comparison With Peers:

As per RHP no listed peers of the company.

Recommendation on Hamps Bio Limited IPO:

Review and Recommendation of Hamps Bio IPO by team IZ is 3/10.
 

Lead Manager of Hamps Bio Limited IPO:

  1. Marwadi Chandarana Intermediaries Brokers Pvt. Ltd.

Registrar of Hamps Bio Limited IPO:

  1. Bigshare Services Private Limited

Company Address:

Hamps Bio Limited 2900/112, GIDC, Near Atul Limited, Ankleshwar, Bharuch 393 002 Phone: +91 8000006663 Email: info@hampsbio.com Website: http://www.hampsbio.com/

Discussion on Hamps Bio Limited IPO:

Leave a Reply